Yes, Jean, I have seen these results. There still is the nagging question of whether we need the full chemo-quotient or can get by with just Herceptin, especially with highly hormone positive tumors where the efficacy of chemo is questionable. Does the associated risk of leukemia and heart disease with ACTH outweigh the benefit, if indeed there is a benefit of chemo for someone with my pathology, of this protocol? That remains to be ascertained. I chose the ACTH based on current knowledge, but always felt it would be proven to have been over exposure, especially with the AC. I suspect in the future we stage 1 a,b'ers will be subjected to a taxol/herceptin protocol only. Again, time will tell!
Ya know I always tell my clients I'd be dangerous with a crystal ball when they want me to predict the future. Sure could use one of those....
__________________
Smile On!
Laurel
Dx'd w/multifocal DCIS/IDS 3/08
7mm invasive component
Partial mast. 5/08
Stage 1b, ER 80%, PR 90%, HER-2 6.9 on FISH
0/5 nodes
4 AC, 4 TH finished 9/08
Herceptin every 3 weeks. Finished 7/09
Tamoxifen 10/08. Switched to Femara 8/09
Bilat SPM w/reconstruction 10/08
Clinical Trial w/Clondronate 12/08
Stopped Clondronate--too hard on my gizzard!
Switched back to Tamoxifen due to tendon pain from Femara
15 Years NED
I think I just might hang around awhile....
|